deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05804227

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

Sponsor: BioMed Valley Discoveries, Inc

Conditions Gliomas
Interventions Ulixertinib
Updated 14 times since 2023 Last updated: Feb 25, 2026 Started: Apr 20, 2023 Primary completion: Sep 22, 2027 Completion: Sep 22, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Gliomas, this trial is actively recruiting participants. The trial is conducted by BioMed Valley Discoveries, Inc and has accumulated 14 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2023 – ~Aug 2023 · 3 months · monthly snapshot~Aug 2023 – ~Oct 2023 · 2 months · monthly snapshot~Oct 2023 – ~Feb 2024 · 4 months · monthly snapshotRecruiting~Feb 2024 – ~May 2024 · 3 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~May 2025 · 5 months · monthly snapshotRecruiting~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Jan 2026 · 6 months · monthly snapshotRecruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

14 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Jan 2026 — Feb 2026 [monthly]

    Recruiting EARLY_PHASE1

  3. Jul 2025 — Jan 2026 [monthly]

    Recruiting EARLY_PHASE1

  4. Jun 2025 — Jul 2025 [monthly]

    Recruiting EARLY_PHASE1

  5. May 2025 — Jun 2025 [monthly]

    Recruiting EARLY_PHASE1

▶ Show 9 earlier versions

  1. Dec 2024 — May 2025 [monthly]

    Recruiting EARLY_PHASE1

  2. Nov 2024 — Dec 2024 [monthly]

    Recruiting EARLY_PHASE1

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting EARLY_PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting EARLY_PHASE1

    Phase: PHASE1 → EARLY_PHASE1

  5. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  6. Feb 2024 — May 2024 [monthly]

    Recruiting PHASE1

  7. Oct 2023 — Feb 2024 [monthly]

    Recruiting PHASE1

  8. Aug 2023 — Oct 2023 [monthly]

    Recruiting PHASE1

  9. May 2023 — Aug 2023 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BioMed Valley Discoveries, Inc
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations